Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Cash from Financing (Quarterly): 7.199M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.199M |
| December 31, 2023 | 0.527M |
| September 30, 2023 | 35.32M |
| June 30, 2023 | 108.17M |
| March 31, 2023 | 26.46M |
| December 31, 2022 | 0.553M |
| September 30, 2022 | 0.68M |
| June 30, 2022 | 0.68M |
| March 31, 2022 | 16.92M |
| December 31, 2021 | 2.173M |
| September 30, 2021 | 1.381M |
| June 30, 2021 | 125.39M |
| March 31, 2021 | 0.979M |
| December 31, 2020 | 126.98M |
| September 30, 2020 | 7.669M |
| June 30, 2020 | 112.58M |
| March 31, 2020 | 0.399M |
| December 31, 2019 | 9.779M |
| September 30, 2019 | 25.24M |
| Date | Value |
|---|---|
| June 30, 2019 | 10.63M |
| March 31, 2019 | 0.39M |
| December 31, 2018 | 0.479M |
| September 30, 2018 | 23.03M |
| June 30, 2018 | 0.074M |
| March 31, 2018 | 0.53M |
| December 31, 2017 | 65.06M |
| September 30, 2017 | 0.031M |
| June 30, 2017 | 0.087M |
| March 31, 2017 | 0.374M |
| December 31, 2016 | -0.852M |
| September 30, 2016 | 85.28M |
| June 30, 2016 | -0.75M |
| March 31, 2016 | 22.63M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 17.36M |
| June 30, 2015 | 0.055M |
| March 31, 2015 | 0.002M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.399M
Minimum
Mar 2020
126.98M
Maximum
Dec 2020
30.99M
Average
8.724M
Median
Cash from Financing (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 40.93M |
| SELLAS Life Sciences Group Inc | 26.65M |
| Akebia Therapeutics Inc | 18.48M |
| Immuneering Corp | 0.9799M |
| Moderna Inc | 14.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.43M |
| Cash from Investing (Quarterly) | 6.071M |
| Free Cash Flow | -64.16M |
| Free Cash Flow Per Share (Quarterly) | -0.4351 |
| Free Cash Flow to Equity (Quarterly) | -27.67M |
| Free Cash Flow to Firm (Quarterly) | -27.67M |
| Free Cash Flow Yield | -3.48% |